Incidence, risk factors, and outcomes of stroke post‐transplantation in patients receiving a steroid sparing immunosuppression protocol
- 19 November 2014
- journal article
- research article
- Published by Wiley in Clinical Transplantation
- Vol. 29 (1) , 18-25
Abstract
Corticosteroid use after transplantation is associated with an increased incidence of cardiovascular events and death. Cerebrovascular disease is a common cause of morbidity and mortality post‐renal transplantation; however, a dedicated analysis of cerebrovascular disease in recipients of a steroid sparing protocol has not been reported. The aim of this study was to examine the incidence, risk factors, and outcomes of CVA in transplant recipients receiving a steroid sparing protocol. We retrospectively analyzed 1237 patients who received a kidney alone or a simultaneous pancreas and kidney (SPK) transplant. Fifty‐six of 1237 (4.53%) patients had a CVA post‐transplant. All‐cause mortality was significantly higher in the CVA group compared with the non‐CVA group, OR: 3.4 (1.7–7.0), p < 0.001. Factors found to be associated with increased risk of CVA by multivariate analysis were older age, HR: 1.07 (1.04–1.09), p < 0.001; diabetes at the time of transplantation, HR: 2.83 (1.42–5.64), p = 0.003; corticosteroid use pre‐transplant, HR: 3.27 (1.29–8.27), p = 0.013 and recipients of a SPK, HR: 4.03 (1.85–8.79), p < 0.001. This study has identified subgroups of patients who are at increased risk of CVA post‐transplant in patients otherwise receiving a steroid sparing immunosuppression protocol.Keywords
This publication has 31 references indexed in Scilit:
- Association Between Steroid Dosage and Death With a Functioning Graft After Kidney TransplantationAmerican Journal of Transplantation, 2013
- Cardiovascular Assessment of Diabetic End-Stage Renal Disease Patients Before Renal TransplantationTransplantation, 2011
- Steroid Avoidance or Withdrawal After Renal Transplantation Increases the Risk of Acute Rejection but Decreases Cardiovascular Risk. A Meta-AnalysisTransplantation, 2010
- Twelve-Month Pancreas Graft Function Significantly Influences Survival Following Simultaneous Pancreas-Kidney TransplantationClinical Journal of the American Society of Nephrology, 2009
- Incremental Value of the Pancreas Allograft to the Survival of Simultaneous Pancreas-Kidney Transplant RecipientsDiabetes Care, 2009
- Variations in the Risk for Cerebrovascular Events after Kidney Transplant Compared with Experience on the Waiting List and after Graft FailureClinical Journal of the American Society of Nephrology, 2008
- Cardiovascular Outcomes in the Outpatient Kidney Transplant ClinicClinical Journal of the American Society of Nephrology, 2008
- Management of Cardiovascular Disease in Renal Transplant RecipientsClinical Journal of the American Society of Nephrology, 2008
- Macrovascular disease after simultaneous pancreas and kidney transplantationClinical Transplantation, 2004
- Effect of simultaneous pancreas-kidney transplantation on mortality of patients with type-1 diabetes mellitus and end-stage renal failureThe Lancet, 1999